BOSTON - Haemonetics Corporation (NYSE: NYSE:HAE), a global healthcare company, has scheduled the release of its third quarter fiscal year 2024 financial results for early morning on February 8, 2024. Following the announcement, the company will host a conference call with investors and analysts at 8:00 am ET to discuss the quarterly outcomes and field questions.
Participants interested in joining the conference call can register for the teleconference, which will provide them with a personalized PIN for access.
Additionally, a live webcast of the conference call will be available on the investor relations section of Haemonetics' website. For those unable to attend the live event, a replay will be accessible starting at 11:00 am ET on the day of the call and will remain available for one year.
Haemonetics is known for its medical products and solutions that focus on blood and plasma component collection, the surgical suite, and hospital transfusion services. These technologies are designed to enhance patient care while aiming to reduce healthcare costs.
This announcement is based on a press release statement from Haemonetics Corporation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.